Patents by Inventor Kyeong Woo MIN

Kyeong Woo MIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hemostatic composition comprising cross-linked hyaluronic acid derivative matrix
    Patent number: 11602539
    Abstract: The present invention relates to a hemostatic composition and a method for preparing thereof, and more specifically, relates to a hemostatic composition comprising a cross-linked hyaluronic acid derivative matrix which is suitable to be used for hemostasis and a method of preparation of such a composition.
    Type: Grant
    Filed: September 6, 2017
    Date of Patent: March 14, 2023
    Assignee: BMI KOREA CO., LTD
    Inventors: Min-Kyoung Kim, Koo Woo, Yeong Jun Baik, Kyeong Woo Min
  • COMPOSITION, FOR OSTEOARTHRITIS TREATMENT, COMPRISING HYDROPHILIZED SULFASALAZINE AND HYALURONIC ACID AND METHOD FOR PREPARING SAME
    Publication number: 20210145850
    Abstract: The present invention relates to a composition for treating osteoarthritis and a method for preparing the same, and more specifically, relates to a composition comprising hydrophilized sulfasalazine as an active ingredient and hyaluronic acid so as to enable effective treatment of osteoarthritis such as degenerative osteoarthritis by preventing joint wear in addition to symptom relief through intraarticular or local administration, and a method for preparing the same.
    Type: Application
    Filed: January 26, 2021
    Publication date: May 20, 2021
    Inventors: Suhwan KIM, Kyeong Woo MIN, Yeong Jun BAIK, Sung Hee LEE, Koo WOO, Min-Kyoung KIM
  • COMPOSITION, FOR OSTEOARTHRITIS TREATMENT, COMPRISING HYDROPHILIZED SULFASALAZINE AND HYALURONIC ACID AND METHOD FOR PREPARING SAME
    Publication number: 20200138834
    Abstract: The present invention relates to a composition for treating osteoarthritis and a method for preparing the same, and more specifically, relates to a composition comprising hydrophilized sulfasalazine as an active ingredient and hyaluronic acid so as to enable effective treatment of osteoarthritis such as degenerative osteoarthritis by preventing joint wear in addition to symptom relief through intraarticular or local administration, and a method for preparing the same.
    Type: Application
    Filed: December 19, 2019
    Publication date: May 7, 2020
    Inventors: Suhwan Kim, Kyeong Woo Min, Yeong Jun Baik, Sung Hee Lee, Koo Woo, Min-Kyoung Kim
  • Composition for injection of hyaluronic acid, containing hyaluronic acid derivative and DNA fraction, and use thereof
    Patent number: 10456347
    Abstract: The present invention refers to the injectable hyaluronic acid composition which is crosslinked viscoelastic hyaluronic acid gel comprising DNA fractions. More particularly, it refers to the injectable hyaluronic acid composition comprising a hyaluronic acid composition crosslinked in the basic conditions with the degree of crosslinking between 0.1 and 200%, which is mixed with the DNA fractions of 0.1 to 50 wt %. The DNA fractions are selected, for example, from polynucleotide (PN) and polydeoxyribonucleotide (PDRN). The composition used for cosmetic purposes or therapeutic purposes, have improved viscoelastic rheological properties and enzyme resistance.
    Type: Grant
    Filed: November 24, 2016
    Date of Patent: October 29, 2019
    Assignee: BMI KOREA CO., LTD
    Inventors: Min-Kyoung Kim, Koo Woo, Yeong Jun Baik, Sung Hee Lee, Kyeong Woo Min
  • HEMOSTATIC COMPOSITION COMPRISING CROSS-LINKED HYALURONIC ACID DERIVATIVE MATRIX
    Publication number: 20190201436
    Abstract: The present invention relates to a hemostatic composition and a method for preparing thereof, and more specifically, relates to a hemostatic composition comprising a cross-linked hyaluronic acid derivative matrix which is suitable to be used for hemostasis and a method of preparation of such a composition.
    Type: Application
    Filed: September 6, 2017
    Publication date: July 4, 2019
    Inventors: Min-Kyoung KIM, Koo WOO, Yeong Jun BAIK, Kyeong Woo MIN
  • COMPOSITION, FOR OSTEOARTHRITIS TREATMENT, COMPRISING HYDROPHILIZED SULFASALAZINE AND HYALURONIC ACID AND METHOD FOR PREPARING SAME
    Publication number: 20180344750
    Abstract: The present invention relates to a composition for treating osteoarthritis and a method for preparing the same, and more specifically, relates to a composition comprising hydrophilized sulfasalazine as an active ingredient and hyaluronic acid so as to enable effective treatment of osteoarthritis such as degenerative osteoarthritis by preventing joint wear in addition to symptom relief through intraarticular or local administration, and a method for preparing the same.
    Type: Application
    Filed: December 16, 2016
    Publication date: December 6, 2018
    Inventors: Suhwan KIM, Kyeong Woo MIN, Yeong Jun BAIK, Sung Hee LEE, Koo WOO, Min-Kyoung KIM
  • COMPOSITION FOR INJECTION OF HYALURONIC ACID, CONTAINING HYALURONIC ACID DERIVATIVE AND DNA FRACTION, AND USE THEREOF
    Publication number: 20180325798
    Abstract: The present invention refers to the injectable hyaluronic acid composition which is crosslinked viscoelastic hyaluronic acid gel comprising DNA fractions. More particularly, it refers to the injectable hyaluronic acid composition comprising a hyaluronic acid composition crosslinked in the basic conditions with the degree of crosslinking between 0.1 and 200%, which is mixed with the DNA fractions of 0.1 to 50 wt %. The DNA fractions are selected, for example, from polynucleotide (PN) and polydeoxyribonucleotide (PDRN). The composition used for cosmetic purposes or therapeutic purposes, have improved viscoelastic rheological properties and enzyme resistance.
    Type: Application
    Filed: November 24, 2016
    Publication date: November 15, 2018
    Inventors: Min-Kyoung KIM, Koo WOO, Yeong Jun BAIK, Sung Hee LEE, Kyeong Woo MIN